Anaesthesia · 2005 · 23 citations · 26 references
MedicineHematologyPharmacologyClinical CardiologyClinical PharmacologyHemostasisAntiplatelet TherapyAntithrombotic TherapyCardiovascular DiseasePlatelet ActivationPlatelet FunctionPlatelet PhysiologyAntiplatelet DrugsAntiplatelet Therapy AssessmentAspirin ResponseOperative Blood LossPostoperative Cardiac Surgical Care
Continuing aspirin up until surgery in cardiac surgical patients may increase peri-operative blood loss. It is possible that there is a subset of patients particularly sensitive to aspirin. The platelet function analyser (PFA-100) can demonstrate the antiplatelet effect of aspirin. This study was designed to assess the effect of daily 75 mg aspirin on platelet function, as measured by the PFA-100, in 92 patients with ischaemic heart disease. Patients were classified into three groups according to their PFA-100 results; aspirin hyper-responders (16%), aspirin normal responders (33%) and aspirin non-responders (51%). The PFA-100 has potential as a screening tool to identify patients who are either hyper-responsive or resistant to aspirin. Pre-operative PFA-100 screening to isolate aspirin hyper-responders could enable the vast majority of patients to continue with aspirin therapy pre-operatively, avoiding the risks of stopping treatment.
26
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
Eugène McFadden, Eugenio Stabile, Evelyn Regar et al. · The Lancet · 2004 · 1.4K citations
Medicine, Cardiology, Pharmacology +16
The way I see it: House officers need formal career development
Andy M. Connor · BMJ · 2002 · 1.1K citations
Education, Human Resource Management, Workforce Development +6
Aspirin and Mortality from Coronary Bypass Surgery
Dennis T. Mangano · New England Journal of Medicine · 2002 · 677 citations · Full text
Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
Monika Homoncik, Bernd Jilma, Nicole Hergovich et al. · PubMed · 2000 · 195 citations